ResultsIQ › Latest results › Park Medi World Limited
Park Medi World Limited Q3 FY26 results deck summary
NSE: PARKHOSPS · BSE: 544645
Results deck of 28 Jan 2026, summarised by AI from the filing.
Q3 FY26 revenue ₹4,100 mn, EBITDA ₹994 mn, PAT ₹528 mn; acquired Febris and KPIMS hospitals.
Key takeaways
- Q3 FY26 revenue Revenue ₹4,100 mn (Q3 FY25: ₹3,481 mn, +17.76%).
- Q3 FY26 EBITDA EBITDA ₹994 mn (Q3 FY25: ₹828 mn, +20.05%).
- Q3 FY26 PAT PAT ₹528 mn (Q3 FY25: ₹456 mn, +15.78%).
Park Medi World Limited Q1 FY27 results
As filed: Revenue ₹476 cr, EBITDA ₹126 cr, PAT ₹88.6 cr, EBITDA margin 26.5%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹476 cr). Scored once a year-earlier consolidated quarter exists.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹460 cr, EBITDA ₹127 cr, PAT ₹76.8 cr, EBITDA margin 27.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹460 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +5.2% in 30 days (Nifty 500: −3.0%).
- Q3 FY26: Revenue ₹410 cr, EBITDA ₹99.4 cr, PAT ₹52.9 cr, EBITDA margin 24.3%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹410 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +29.5% in 30 days (Nifty 500: +1.5%).
Past price moves after results do not indicate future moves. Not a recommendation.
Park Medi World Limited earnings call, investor presentation and press release summaries
Figures from the company's filings with NSE and BSE. Not investment advice.